ADMA Biologics Inc (ADMA) — Free Cash Flow Generation Index

Latest as of March 2026: 0.96x

ADMA Biologics Inc (ADMA) has a Free Cash Flow Generation Index of 0.96x as of March 2026. Free cash flow of $55.71 Million represents 1% of operating cash flow ($58.25 Million). See ADMA Biologics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

$55.71 Million
USD

Operating Cash Flow

$58.25 Million
USD

Capital Expenditures

$2.54 Million
USD

ADMA Biologics Inc Free Cash Flow Generation Index (2023–2025)

Historical FCF Generation Index trend for ADMA Biologics Inc across 3 annual periods. Explore how well can ADMA Biologics Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for ADMA Biologics Inc (2023–2025)

Year-by-year Free Cash Flow Generation Index for ADMA Biologics Inc. For the full company profile including market capitalisation, see ADMA Biologics Inc market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.55x $27.82 Million $50.40 Million $22.57 Million ▼ -40.5%
2024 0.93x $110.10 Million $118.67 Million $8.57 Million ▲ +113.8%
2023 0.43x $3.82 Million $8.80 Million $4.98 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).